Literature DB >> 12040974

Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction.

T J Bunch1, D Abraham, S Wang, A W Meikle.   

Abstract

The prevalence of erectile dysfunction rises rapidly with age and is a frequent complaint presented in clinical practice. Although the etiology of erectile dysfunction is multifactorial, 10-20% of evaluations demonstrate testosterone deficiency. Testosterone deficiency due to secondary hypogonadism increases with age. Despite a higher prevalence of secondary hypogonadism in the elderly, there are no studies addressing hypothalamic-pituitary structural abnormalities in elderly impotent men with testosterone deficiency. We retrospectively reviewed the records of all elderly men who presented for general outpatient evaluation of erectile dysfunction from 1996 to 1999. To obtain a cohort control population, the records of 300 patients without erectile dysfunction were also reviewed. Amongst the erectile dysfunction patients, 225 were found to be testosterone deficient (testosterone < 300 ng/dl). Of these patients, 29 were additionally diagnosed with secondary hypogonadism based on a luteinizing hormone (LH) < 13 mIU/ml. Magnetic resonance imaging (MRI) or computed tomography (CT) imaging was available and reviewed in all patients diagnosed with secondary hypogonadism. Ten per cent of these patients had hypothalamic-pituitary imaging abnormalities. The prevalence of pituitary tumors within our population was not significantly elevated compared to the previous general population studies. Small-vessel white matter disease, hyperlipidemia and history of compression fractures were significantly increased in both univariate and multivariate analysis in the erectile dysfunction group compared with the control cohort. This study does not suggest that the use of hypothalamic-pituitary imaging in the evaluation of impotence in elderly men, in the absence of clinical characteristics of other hormonal loss or sella compression symptoms, will increase diagnosis of structural hypothalamic-pituitary abnormalities over that of the general population. However, the yield may increase with very low testosterone levels. These data suggest that there is an increase in ischemic white matter disease in elderly men with hypogonadism that may reflect microvascular injury to the hypothalamic-pituitary. Furthermore, these data confirm that low testosterone is associated with hyperlipidemia in the elderly. Future studies are required to assess the role of hypogonadism and hyperlipidemia, and to determine if treatment of the hormone deficiency improves the lipid profile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040974

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  9 in total

1.  A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians.

Authors:  Alvaro Morales; Anthony J Bella; Samuel Chun; Jay Lee; Peter Assimakopoulos; Richard Bebb; Irv Gottesman; Pierre Alarie; Hélène Dugré; Stacy Elliott
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

2.  Increased abnormal pituitary findings on magnetic resonance in patients with male idiopathic hypogonadotrophic hypogonadism.

Authors:  S E Bolu; M Tasar; G Uçkaya; E Gönül; F Deniz; I C Ozdemir
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

3.  Pituitary imaging findings in male patients with hypogonadotrophic hypogonadism.

Authors:  Dania Hirsch; Carlos Benbassat; Yoel Toledano; Irena S'chigol; Gloria Tsvetov; Ilana Shraga-Slutzky; Yoav Eizenberg; Ilan Shimon
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

Review 4.  Testosterone deficiency in the aging male.

Authors:  J Abram McBride; Culley C Carson; Robert M Coward
Journal:  Ther Adv Urol       Date:  2016-02

5.  Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.

Authors:  Bruno Lunenfeld; George Mskhalaya; Michael Zitzmann; Stefan Arver; Svetlana Kalinchenko; Yuliya Tishova; Abraham Morgentaler
Journal:  Aging Male       Date:  2015-02-06       Impact factor: 5.892

6.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

7.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664

Review 8.  Andropause: Current concepts.

Authors:  Parminder Singh
Journal:  Indian J Endocrinol Metab       Date:  2013-12

9.  Biochemical predictors of structural hypothalamus-pituitary abnormalities detected by magnetic resonance imaging in men with secondary hypogonadism.

Authors:  S Cipriani; T Todisco; N Ghiandai; L Vignozzi; G Corona; M Maggi; G Rastrelli
Journal:  J Endocrinol Invest       Date:  2021-05-10       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.